C12N 2760/14161
Methods of inactivation or attenuation
C12N2760/14161 (Methods of inactivation or attenuation) appears on 6 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 8
- Assignees
- 6
- Inventors
- 15
- Latest grant
- 31 Jul 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 2 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 2 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- RNA interference functions as an antiviral immunity in mammals31 Jul 2018US 10,034,929 B2The Regents of the University of California
- Device and method of collection for RNA viruses19 Jun 2018US 10,000,742 B2General Electric Company
- Recombinant human CC10 protein for treatment of influenza and ebola27 Oct 2015US 9,168,285 B2Therabron Therapeutics, Inc.
- Cellular and viral inactivation24 Dec 2013US 8,613,934 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Inactivated influenza virus compositions2 Oct 2012US 8,278,083 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Compositions and methods useful for ebola virus infection10 Nov 2022US 2022/0356476 A1AIM ImmunoTech Inc.
- Device and method of collection for rna viruses27 Sep 2018US 2018/0273914 A1General Electric Company
- Device and method of collection for rna viruses25 May 2017US 2017/0145387 A1General Electric Company
- Rna interference functions as an antiviral immunity in mammals2 Feb 2017US 2017/0028051 A1The Regents of the University of California
- Recombinant human cc10 protein for treatment of influenza and ebola11 Jun 2015US 2015/0157689 A1Therabron Therapeutics, Inc.
Most cited
By later US patents
- Cellular and viral inactivation2US 8,613,934 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2013
- Cellular and viral inactivation1US 8,268,602 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2012
- Inactivated influenza virus compositions1US 8,278,083 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2012